What is already known about this subject
N,N-dimethyltryptamine (DMT) is a psychedelic compound in clinical
development for the treatment of major depressive disorder
It has been previously established that DMT is rapidly metabolised
following intravenous (IV) administration; however, the complete
pharmacokinetic (PK) profile of DMT in humans has not been fully
characterised